Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Hongye Pharmaceutical is a China-based pharmaceutical company primarily engaged in the research, development, production, and sale of finished drug products and active pharmaceutical ingredients (APIs). The company operates modern manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards, producing a variety of dosage forms including tablets, capsules, and granules. Its product portfolio spans several therapeutic areas such as cardiovascular health, respiratory medicine, and gastrointestinal treatments, often integrating traditional Chinese medicine with modern pharmaceutical science. Anhui Hongye Pharmaceutical focuses on providing high-quality, affordable generic medications to the domestic Chinese market and international regions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui Hongye Pharmaceutical.